{"id":51252,"date":"2021-03-16T00:00:00","date_gmt":"2021-03-16T00:00:00","guid":{"rendered":"http:\/\/medgoo.com\/index.php\/2021\/03\/16\/immediate-start-of-art-for-hiv-may-impact-10-year-risk-for-cancer\/"},"modified":"2021-03-18T15:10:57","modified_gmt":"2021-03-18T15:10:57","slug":"immediate-start-of-art-for-hiv-may-impact-10-year-risk-for-cancer","status":"publish","type":"post","link":"https:\/\/medgoo.com\/index.php\/2021\/03\/16\/immediate-start-of-art-for-hiv-may-impact-10-year-risk-for-cancer\/","title":{"rendered":"Immediate Start of ART for HIV May Impact 10-Year Risk for Cancer"},"content":{"rendered":"<h3>\n<p>Deferral of antiretroviral therapy may lead to small increase in risk for AIDS-defining cancer <\/p>\n<\/h3>\n<p><b><\/b><\/p>\n<p><b><\/b><\/p>\n<p>TUESDAY, March 16, 2021 (HealthDay News) &#8212; For people with HIV, deferral of antiretroviral therapy (ART) has a small effect on increasing the 10-year risk for cancer, according to a study published online March 16 in the <em>Annals of Internal Medicine<\/em>.<\/p>\n<p>Fr \u00a9d \u00a9rique Chammartin, Ph.D., from the University of Basel in Switzerland, and colleagues estimated the long-term risk difference for cancer with an immediate ART strategy in the Data collection on Adverse events of anti-HIV Drugs study. Data were included for 8,318 HIV-positive persons. The 10-year risks for non-AIDS-defining and AIDS-defining cancer were compared for immediate versus deferred ART initiation strategies.<\/p>\n<p>The researchers identified 231 cases of non-AIDS-defining cancer and 272 cases of AIDS-defining cancer during 64,021 person-years of follow-up among HIV-positive persons (median age, 36 years). With immediate ART, the 10-year risks for non-AIDS-defining and AIDS-defining cancer were 2.97 and 2.50 percent, respectively. When deferring ART to CD4 counts less than 500 x 10<sup>9<\/sup> cells\/L and less than 350 x 10<sup>9<\/sup> cells\/L, the 10-year absolute risk differences were 0.12 (95 percent confidence interval, \u00e2\u0088\u00920.01 to 0.26) and 0.29 (95 percent confidence interval, \u00e2\u0088\u00920.03 to 0.73) percentage points, respectively, for non-AIDS-defining cancer and 0.32 (95 percent confidence interval, 0.21 to 0.44) and 1.00 (95 percent confidence interval, 0.67 to 1.44) percentage points, respectively, for AIDS-defining cancer compared with immediate ART initiation.<\/p>\n<p>&#8220;We observed that strategies promoting deferral of ART initiation in ART-naive, HIV-positive persons are associated with a small increase in risk for AIDS-defining cancer,&#8221; the authors write.<\/p>\n<p>Several pharmaceutical companies provided funding for the study.<\/p>\n<p><a href=\"https:\/\/www.acpjournals.org\/doi\/10.7326\/M20-5226\" target=\"_blank\" rel=\"noopener\">Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n<p><i><\/i><\/p>\n<p><i>Copyright \u00a9 2020 <a href=\"https:\/\/www.healthday.com\/\" target=\"_new\" rel=\"noopener\">HealthDay<\/a>. All rights reserved.<\/i><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Deferral of antiretroviral therapy may lead to small increase in risk for AIDS-defining cancer <\/p>\n","protected":false},"author":6,"featured_media":51456,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[11],"class_list":["post-51252","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news"],"_links":{"self":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/51252","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/comments?post=51252"}],"version-history":[{"count":0,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/posts\/51252\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media\/51456"}],"wp:attachment":[{"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/media?parent=51252"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/categories?post=51252"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medgoo.com\/index.php\/wp-json\/wp\/v2\/tags?post=51252"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}